Positron emission tomography studies of human airways using an inhaled β-adrenoceptor antagonist, S-11C-CGP12388

Chest

Volumn 128, Issue 4, 2005, Pages 3020-3027

  Van Waarde, Aren ^a   Maas, Bram ^a   Doze, Petra ^a   Slart, Riemer H ^a   Frijlink, Henderik W ^b   Vaalburg, Willem ^a   Elsinga, Philip H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Airways; Lung; Positron emission tomography; Radioaerosol; adrenoceptors

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBON 11; CGP 12388; PINDOLOL; RADIOLIGAND; SALBUTAMOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DRUG RECEPTOR BINDING; DRUG TISSUE LEVEL; DRUG UPTAKE; FEMALE; HUMAN; HUMAN EXPERIMENT; ISOTOPE LABELING; LIGAND BINDING; LUNG ALVEOLUS; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; WHOLE BODY SCINTISCANNING;

EID: 27144535896     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.4.3020     Document Type: Article

References (35)

1. Barnes PJ. Neural control of airway smooth muscle. In: Crystal RG, West JB, eds. The lung: scientific foundations. Philadelphia, PA: Lippincott-Raven, 1997; 1269-1285
2. Barnes PJ. β-adrenergic receptors and their regulation. Am J Respir Crit Care Med 1995; 152:838-860
3. Barnes PJ. Neural mechanisms in asthma. Br Med Bull 1992; 48:149-168
4. Goldie RG. Receptors in asthmatic airways. Am Rev Respir Dis 1990; 141:S151-S156
5. Qing F, Rahman SU, Rhodes CG, et al. Pulmonary and cardiac β-adrenoceptor density in vivo in asthmatic subjects. Am J Respir Crit Care Med 1997; 155:1130-1134
6. Rahman SU, Qing F, Rhodes CG, et al. Regulation of pulmonary β-2 adrenergic receptor expression: concordance between receptor density, function and genotypes [abstract]. Am J Respir Crit Care Med 1997; 155:A855
7. 2-agonist dosing on human cardiac β-adrenoceptor expression in vivo: comparison with changes in lung and mononuclear leukocyte beta-receptors. J Nucl Cardiol 1997; 4:532-538
8. Hayes MJ, Qing F, Rhodes CG, et al. In vivo quantification of human pulmonary beta-adrenoceptors: effect of β-agonist therapy. Am J Respir Crit Care Med 1996; 154:1277-1283
9. 11C-S-CGP12177 [abstract]. Thorax 1992; 47:871
10. Carstairs JR, Nimmo AJ, Barnes PJ. Autoradiographic visualization of β-adrenoceptor subtypes in human lung. Am Rev Respir Dis 1985; 132:541-547
11. Qing F, Rhodes CG, Hayes MJ, et al. M. B. In vivo quantification of human pulmonary beta-adrenoceptor density using PET: comparison with in vitro radioligand binding. J Nucl Med 1996; 37:1275-1281
12. Engels F, Carstairs JR, Barnes PJ, et al. Autoradiographic localization of changes in pulmonary β-adrenoceptors in an animal model of atopy. Eur J Pharmacol 1989; 164:139-146
13. 18F]Fluoro-CGP 12388) for visualization of β-adrenoceptors with positron emission tomography. J Med Chem 1997; 40:3829-3835
14. Van Waarde A, Elsinga PH, Doze P, et al. A novel β-adrenoceptor ligand for positron emission tomography: evaluation in experimental animals. Eur J Pharmacol 1998; 343:289-296
15. 11C]CGP 12388 and a tracer kinetic model. Eur J Nucl Med 2002; 29:295-304
16. 11C]CGP 12388 and positron emission tomography. Eur J Pharmacol 2001; 433:173-176
17. Giordano A, Calcagni ML, Rossi B, et al. Potential use of iodine-123 metaiodobenzylguanidine radioaerosol as a marker of pulmonary neuroadrenergic function. Eur J Nucl Med 1997; 24:52-58
18. Brodde OE, Karad K, Zerkowski HR, et al. Coexistence of β1- and β2-adrenoceptors in human heart and lung [abstract]. Br J Pharmacol 1983; 78(suppl):72
19. Engel G. Subclasses of β-adrenoceptors: a quantitative estimation of β 1- and β 2-adrenoceptors in guinea pig and human lung. Postgrad Med J 1981; 57(suppl)1:77-83
20. 3H]dihydroalprenolol binding to beta1- and beta2-noradrenergic receptors in brain, heart, and lung membranes. J Biol Chem 1978; 253:5090-5102
21. Van Gameren A, Mes N, De Boer J. Farmacotherapeutisch kompas. Diemen, the Netherlands: College voor Zorgverzekeringen, 2004
22. Horii D, Kawada T, Takeda K, et al. Comparison of β-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig. Arzneimittelforschung 1974; 24:1275-1277
23. 18F]fluorocarazolol. J Nucl Med 1997; 38:169-174
24. Heyder J. Mechanisms of aerosol particle deposition. Chest 1981; 80:820-823
25. Krasnow AZ, Isitiman AT, Collier BD, et al. Diagnostic applications of radioaerosols in nuclear medicine: nuclear medicine annual. New York, NY: Raven Press, 1993; 123-193
26. Miki M, Isawa T, Teshima T, et al. Difference in inhaled aerosol deposition patterns in the lungs due to three different sized aerosols. Nucl Med Commun 1992; 13:553-562
27. Lippmann M, Albert RE. The effect of particle size on the regional deposition of inhaled aerosols in the human respiratory tract. Am Ind Hyg Assoc J 1969; 30:257-275
28. 18FDG powder. J Comput Assist Tomogr 1990; 14:175-181
29. Finlay WH, Stapleton KW, Chan HK, et al. Regional deposition of inhaled hygroscopic aerosols: in vivo SPECT compared with mathematical modeling. J Appl Physiol 1996; 81:374-383
30. Fleming JS, Halson P, Conway J, et al. Three-dimensional description of pulmonary deposition of inhaled aerosol using data from multimodality imaging. J Nucl Med 1996; 37:873-877
31. Hakkinen AM, Uusi-Heikkila H, Jarvinen M, et al. The effect of breathing frequency on deposition of drug aerosol using an inhalation-synchronized dosimeter in healthy adults. Clin Physiol 1999; 19:269-274
32. Van Waarde A, Meeder JG, Blanksma PK, et al. Suitability of CGP12177 and CGP26505 for quantitative imaging of β-adrenoceptors. Nucl Med Biol 1992; 19:711-718
33. Widdicombe J. Drug uptake from the airways and lungs. Indian J Physiol Pharmacol 1998; 42:3-14
34. Lafortuna CL, Fazio F. Acute effect of inhaled salbutamol on mucociliary clearance in health and chronic bronchitis. Respiration 1984; 45:111-123
35. Dorow P, Weiss T, Felix R, et al. Influence of propranolol, metoprolol, and pindolol on mucociliary clearance in patients with coronary heart disease. Respiration 1984; 45:286-290